MARKET

NIKI

NIKI

NIKI BIOSOLUTIONS INC,
NASDAQ
6.46
-0.06
-0.84%
Opening 13:22 09/04 EDT
OPEN
7.15
PREV CLOSE
6.51
HIGH
9.68
LOW
6.05
VOLUME
3.99M
TURNOVER
--
52 WEEK HIGH
25.90
52 WEEK LOW
6.00
MARKET CAP
5.26M
P/E (TTM)
-3.4811
1D
5D
1M
3M
1Y
5Y
1D
Aptorum Group Ltd trading resumes
TipRanks · 3h ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 5h ago
Weekly Report: what happened at NIKI last week (0824-0828)?
Weekly Report · 4d ago
Niki BioSolutions files $75M mixed securities shelf
TipRanks · 08/28 10:15
Weekly Report: what happened at NIKI last week (0817-0821)?
Weekly Report · 08/24 10:11
Aptorum Group GAAP EPS of -$1.60
Seeking Alpha · 08/21 21:10
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 08/20 12:06
Weekly Report: what happened at NIKI last week (0810-0814)?
Weekly Report · 08/17 10:11
More
About NIKI
Aptorum Group Limited is a United Kingdom-based clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. The Company's pipeline is also enriched through the co-development of PathsDx Test, a molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, the commercialization arm of the Singapore's Agency for Science, Technology and Research.

Webull offers Aptorum Group Ltd stock information, including NASDAQ: NIKI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NIKI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NIKI stock methods without spending real money on the virtual paper trading platform.